Best Biotech Stocks To Buy For 2017: Alnylam Pharmaceuticals Inc.(ALNY)
Advisors' Opinion:- [By Paul Ausick]
Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) lost about 50% Thursday to post a new 52-week low of $35.31 after closing Wednesday at $70.30. The 52-week high is $110.75. Volume of around 15 million was more than 20 times the daily average of around 640,000 shares traded. The company said today that it is discontinuing a late-stage clinical trial.
- [By Monica Gerson]
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.Posted-In: Unusual Put OptionsNews Options Markets
source from Top Stocks For 2015:http://www.topstocksblog.com/best-biotech-stocks-to-buy-for-2017.html
No comments:
Post a Comment